Health Systems Core
卫生系统核心
基本信息
- 批准号:10673678
- 负责人:
- 金额:$ 80.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAddressAdoptedAdoptionAlzheimer&aposs DiseaseAlzheimer&aposs disease careAlzheimer&aposs disease related dementiaCaregiversCaringCollaborationsCommunitiesComplexDataDementiaDementia caregiversDevelopmentDiagnosisEffectiveness of InterventionsElectronic Health RecordEmotionalEnsureFinancial HardshipFosteringFoundationsFundingHealth systemHealthcareHealthcare SystemsHeterogeneityHospitalsInstitutionIntegrated Delivery SystemsInterventionK-Series Research Career ProgramsKnowledgeLearningMedicalNational Institute on AgingNursing HomesPatientsPersonsPilot ProjectsPopulationPragmatic clinical trialProtocols documentationProviderReadinessResearchResearch PersonnelResourcesService delivery modelStandardizationSystemTestingUnited States National Institutes of HealthWorkWorld Healthcase findingclinical practicecollaboratorydata exchangedesignefficacious interventionexperiencefeasibility testinghealth care deliveryhealth care service organizationimprovedinformal caregiverinsightknowledge basemedical complicationmeetingsnovelpatient home careprogramsresearch studysuccessful interventionsystems researchtherapy designvirtual
项目摘要
PROJECT SUMMARY
Most persons with dementia (PWD) receive care outside of institutions, meaning that the physical, emotional,
and financial burdens of dementia are borne not only by patients, but their caregivers as well. The fragmented,
complex US health care system exacerbates the challenge of delivering coordinated, whole-person care for
PWD. Designing and testing effective, practicable, non-pharmacological interventions must take into account
the heterogeneity of the health care landscape, the specific needs of this complex population, and the context
in which care is delivered. Although multiple interventions designed to improve care for PWD and their
caregivers have demonstrated efficacy, few have been adopted widely, and virtually none formally tested in
functioning health care systems (HCS). Reflecting the many unanswered questions in optimizing care for
PWD, our imperative is to close the gap between the development and testing of interventions and their later
adoption in real-world HCS. Thus, to develop a robust national capability to support embedded pragmatic
clinical trials (ePCT), we must leverage the combined expertise of researchers and front-line clinicians to
design interventions that ensure replicability, scalability, and sustainability. We will apply this expertise as we
address the unique intricacies of conducting ePCTs focused on meeting the needs of PWD and their
caregivers. The Health Care Systems (HCS) Core of the proposed National Institute on Aging (NIA)
Alzheimer's disease (AD)/AD-related dementia (AD/ADRD) HCS Collaboratory will engage experts from
integrated delivery systems, academic medical centers, nursing home systems, home care companies and
other community based providers to accomplish the following Specific Aims. Aim 1. Establish a collaborative,
supportive research resource involving diverse HCS in order to support and facilitate research in the settings
where PWD and their caregivers receive care; Aim 2. Develop, document, and disseminate setting-specific
approaches to conducting ePCTs in PWD; Aim 3. Facilitate the conduct of rigorous pilot studies, Career
Development Award (CDA) projects, and NIH-funded ePCTs in diverse care HCS targeting PWD and their
caregivers. IMPACT: A successful HCS Core will partner with the other AD/ADRD Collaboratory Cores and
Teams to facilitate rigorous, high-quality research studies focused on PWD and their caregivers, in which
multiple health care delivery organizations participate. Combining deep expertise in ePCTs and first-hand
knowledge of caring for the AD/ADRD population in a range of settings, the HCS Core will become an
unparalleled national research resource to help promulgate successful HCS based interventions designed to
meet the needs of PWD, caregivers, and health systems that serve them.
项目摘要
大多数患有痴呆症(PWD)的人在机构之外接受护理,这意味着身体,情感,
痴呆症的经济负担不仅由患者承担,而且由他们的护理人员承担。分散的,
复杂的美国卫生保健系统加剧了提供协调的全人保健的挑战
PWD。设计和测试有效,可行的非药理学干预措施必须考虑
医疗保健领域的异质性,这个复杂人群的特定需求以及背景
提供护理。尽管多种干预措施旨在改善对PWD及其的护理
看护人已经证明了功效,很少有人被广泛采用,几乎没有正式测试
功能医疗保健系统(HCS)。反映了优化护理的许多未解决的问题
PWD,我们的当务之别是要弥合干预措施的开发和测试之间的差距
在现实世界中采用。因此,建立强大的国家能力来支持嵌入式务实
临床试验(EPCT),我们必须利用研究人员和一线临床医生的综合专业知识
设计干预措施,可确保可复制性,可伸缩性和可持续性。我们将应用这种专业知识
解决了进行EPCT的独特复杂性,旨在满足PWD及其需求
照顾者。拟议的国家老化研究所(NIA)的卫生保健系统(HCS)核心
阿尔茨海默氏病(AD)/与AD相关的痴呆症(AD/ADRD)HCS合作社将吸引专家
综合交付系统,学术医疗中心,疗养院系统,家庭护理公司以及
其他基于社区的提供商可以实现以下特定目标。目标1。建立协作,
涉及各种HCS的支持性研究资源,以支持和促进在设置中的研究
PWD及其护理人员获得护理;目标2。开发,记录和传播特定于设置的设置
在PWD中进行EPCT的方法;目标3。促进严格的试点研究的行为
开发奖(CDA)项目,以及NIH资助的EPCT,用于PWD及其针对PWD的多元化护理HCS
照顾者。影响:成功的HCS核心将与其他广告/ADRD合作核心合作
促进严格的高质量研究的团队集中于PWD及其护理人员,其中
多个医疗保健提供组织参加。结合EPCT和第一手方面的深厚专业知识
了解在各种环境中关心广告/ADRD人口的知识,HCS核心将成为一个
无与伦比的国家研究资源,以帮助颁布成功的基于HCS的干预措施
满足为他们服务的PWD,护理人员和卫生系统的需求。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric B Larson其他文献
Neuropathologic Burden and Dementia in Nonagenarians and Centenarians.
九十多岁和百岁老人的神经病理负担和痴呆。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:9.9
- 作者:
B. Cholerton;Caitlin S. Latimer;Paul K. Crane;M. Corrada;Laura E. Gibbons;Eric B Larson;Claudia H. Kawas;C. D. Keene;T. Montine - 通讯作者:
T. Montine
The epidemiology of Alzheimer’s disease and vascular dementia in Japanese and African-American populations: the search for etiological clues
日本和非裔美国人人群中阿尔茨海默病和血管性痴呆的流行病学:寻找病因线索
- DOI:
- 发表时间:
2000 - 期刊:
- 影响因子:4.2
- 作者:
M. Shadlen;Eric B Larson;Michi Yukawa - 通讯作者:
Michi Yukawa
Eric B Larson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric B Larson', 18)}}的其他基金
Annual Adult Changes in Thought (ACT) symposium on aging, dementia, and Alzheimer's disease
关于衰老、痴呆和阿尔茨海默病的年度成人思想变化 (ACT) 研讨会
- 批准号:
10066181 - 财政年份:2020
- 资助金额:
$ 80.41万 - 项目类别:
Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot
多域阿尔茨海默病风险降低研究 (MARRS) 试点
- 批准号:
9697410 - 财政年份:2017
- 资助金额:
$ 80.41万 - 项目类别:
Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot
多域阿尔茨海默病风险降低研究 (MARRS) 试点
- 批准号:
9422490 - 财政年份:2017
- 资助金额:
$ 80.41万 - 项目类别:
The ACT annual symposium: a living, learning, national collaboratory to advance Alzheimer's disease and brain aging research
ACT 年度研讨会:一个活跃、学习、推进阿尔茨海默病和大脑衰老研究的国家合作机构
- 批准号:
9395822 - 财政年份:2017
- 资助金额:
$ 80.41万 - 项目类别:
Development and Use of Network Infrastructure for High-Throughput GWA Studies
高通量 GWA 研究网络基础设施的开发和使用
- 批准号:
7902293 - 财政年份:2007
- 资助金额:
$ 80.41万 - 项目类别:
Development and Use of Network Infrastructure for High-Throughput GWA Studies
高通量 GWA 研究网络基础设施的开发和使用
- 批准号:
7688756 - 财政年份:2007
- 资助金额:
$ 80.41万 - 项目类别:
Development and Use of Network Infrastructure for High-Throughput GWA Studies
高通量 GWA 研究网络基础设施的开发和使用
- 批准号:
7921317 - 财政年份:2007
- 资助金额:
$ 80.41万 - 项目类别:
Development and Use of Network Infrastructure for High-Throughput GWA Studies
高通量 GWA 研究网络基础设施的开发和使用
- 批准号:
7427364 - 财政年份:2007
- 资助金额:
$ 80.41万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 80.41万 - 项目类别:
AnVIL Clinical Environment for Innovation and Translation (ACE-IT)
AnVIL 创新与转化临床环境 (ACE-IT)
- 批准号:
10747551 - 财政年份:2023
- 资助金额:
$ 80.41万 - 项目类别:
Use of electronic health records in underserved communities in Florida
在佛罗里达州服务欠缺的社区使用电子健康记录
- 批准号:
10580502 - 财政年份:2023
- 资助金额:
$ 80.41万 - 项目类别: